(MedPage Today) — An intranasal adjuvanted recombinant influenza vaccine appeared to safely prompt a robust response to a range of H5N1 clades, according to a phase I trial.
Immune responses among the three groups that received one of three doses…
Source link : https://www.medpagetoday.com/infectiousdisease/birdflu/118414
Author :
Publish date : 2025-11-10 16:28:00
Copyright for syndicated content belongs to the linked Source.
